Reply to “Antiviral therapy improves survival in patients with HBV infection and intrahepatic cholangiocarcinoma undergoing liver resection: novel concerns”

We appreciate the letter from Dr. Sha and colleagues in response to our recent report on antiviral therapy (AVT) in patients with HBV-related intrahepatic cholangiocarcinoma (ICC) undergoing partial hepatectomy.[1] We would like to thank the readers for their interest in our study.
Source: Journal of Hepatology - Category: Gastroenterology Authors: Tags: Letter to the Editor Source Type: research